The North America malaria treatment market is expected to grow from US$ 765.63 million in 2022 to US$ 996.80 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028.
Rapid Diagnostic Tests for Malaria is Bolstering the North America Malaria Treatment Market
RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low-transmission areas is critical to reduce transmission and eliminate the disease. Many companies are engaged in developing a wide range of RDTs with high sensitivities. A few of these developments have taken place in recent years. For instance, in November 2020, researchers from Rice University developed a simple microneedle patch like a bandage to detect malaria. With this development, the researchers have stepped on the path of reducing the disease burden in countries struggling with poor health infrastructure. The microneedles loaded on the patch collect interstitial fluid, which contains several biomarkers that help detect malaria. So, the growing number of rapid diagnostic tests for malaria is driving the North America malaria treatment market.North America Malaria Treatment Market Overview
The North America malaria treatment market is segmented into the US, Canada, and Mexico. The US is dominating the malaria treatment market in the region. According to the Centers for disease control and prevention (CDC), approximately 2,000 cases are reported annually in the United States, mostly in returning travelers and immigrants. Pregnant women and children under five years of age are at the highest risk of contracting malaria and developing severe diseases. Anopheles mosquitoes capable of transmitting malaria (vectors") endure in the US. Thus, there is a perpetual risk that malaria transmission can resume in the US. In April 2022, the Global Fund reported that malaria cases and deaths had risen primarily due to stalled funding and disruptions from the COVID-19 pandemic. However, efforts to mitigate these impacts are in progress, with the Global Fund reporting in September 2022 that programs had recovered from declines. US malaria efforts include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator, and other US activities. For instance, according to Global health policy, US funding for malaria control and research activities was ~US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce malaria deaths further and decrease malaria morbidity toward the long-term goal of elimination. Thus, growing DVT cases and technological advancements in DVT preventive pumps are driving the market's growth.Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Malaria Treatment Market - By Treatment
1.3.2 North America Malaria Treatment Market - By Drug Type
1.3.3 North America Malaria Treatment Market - By Route of Administration
1.3.4 North America Malaria Treatment Market - By Distribution Channel
1.3.5 North America Malaria Treatment Market - By End User
1.3.6 North America Malaria Treatment Market- By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Malaria Treatment Market- Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Malaria Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Government and Private Sector’s Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis
6. Malaria Treatment Market- North America Analysis
6.1 North America Malaria Treatment Market Revenue Forecast and Analysis
7. North America Malaria Treatment Market Analysis - By Treatment
7.1 Overview
7.2 North America Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
7.3.1 Overview
7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Chloroquine Phosphate
7.3.3.1 Overview
7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Artemisinin- based Combination Therapies (ACTs)
7.3.4.1 Overview
7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Atovaquone-Proguanil
7.3.5.1 Overview
7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
7.3.6.1 Overview
7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
7.3.7 Primaquine Phosphate
7.3.7.1 Overview
7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
7.5.1 Overview
7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Malaria Treatment Market Analysis - By Drug Type
8.1 Overview
8.2 North America Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
8.4.1 Overview
8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Malaria Treatment Market Analysis - By Route of Administration
9.1 Overview
9.2 North America Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
9.3.1 Overview
9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
9.4.1 Overview
9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)
10. North America Malaria Treatment Market Analysis - By Distribution Channel
10.1 Overview
10.2 North America Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
10.3.1 Overview
10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
10.5.1 Overview
10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
10.6.1 Overview
10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. North America Malaria Treatment Market Analysis - By End User
11.1 Overview
11.2 North America Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
11.5.1 Overview
11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. North America Malaria Treatment Market - Country Analysis
12.1 Overview
12.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.2 US: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.1.2.1 US: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.1.3 US: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.1.4 US: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.1.5 US: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.1.6 US: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
12.1.1.2 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.2 Canada: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.2.2.1 Canada: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.2.3 Canada: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.2.4 Canada: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.2.5 Canada: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.2.6 Canada: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
12.1.1.3 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.2 Mexico: Malaria Treatment Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.3.2.1 Mexico: Malaria Treatment Market, by Prescription Medication, 2019-2028 (US$ Million)
12.1.1.3.3 Mexico: Malaria Treatment Market, by Drug Type, 2019-2028 (US$ Million)
12.1.1.3.4 Mexico: Malaria Treatment Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.3.5 Mexico: Malaria Treatment Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.3.6 Mexico: Malaria Treatment Market, by End User, 2019-2028 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Zydus Healthcare Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi SA
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GSK Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Cipla Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Viatris Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lupin Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 VLP Therapeutics LLC
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. North America Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Malaria Treatment Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Malaria Treatment Market, by Prescription Medication - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Malaria Treatment Market, by Drug Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Malaria Treatment Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies
Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 22. Glossary of Terms
List of Figures
Figure 1. North America Malaria Treatment Market Segmentation
Figure 2. North America Malaria Treatment Market Segmentation, By Country
Figure 3. North America Malaria Treatment Market Overview
Figure 4. North America Malaria Treatment Market, By Distribution Channel
Figure 5. North America Malaria Treatment Market, By Country
Figure 6. North America PEST Analysis
Figure 7. North America Malaria Treatment Market impact analysis of driver and restraints
Figure 8. North America Malaria Treatment Market - Revenue Forecast and Analysis
Figure 9. North America Malaria Treatment Market, by Treatment 2021 & 2028 (%)
Figure 10. Prescription Medication: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Chloroquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Artemisinin- based Combination Therapies (ACTs): North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Atovaquone-Proguanil: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Primaquine Phosphate: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Vaccines: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Diagnostic Tests: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
Figure 21. Branded: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Generics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
Figure 24. Oral: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Parenteral and Intravenous Mode: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
Figure 27. Direct Tender: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Hospital Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Retail Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Online Pharmacies: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. North America Malaria Treatment Market, by End User 2021 & 2028 (%)
Figure 33. Hospitals: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Specialty Clinics: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Homecare: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Others: North America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. North America: Malaria Treatment Market, by Key Country - Revenue (2021) (US$ Million)
Figure 38. North America: Malaria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. US: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Canada: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Mexico: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma USA LLC
- Cipla Ltd
- GSK Plc
- Lupin Ltd
- Novartis AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd
- Viatris Inc
- VLP Therapeutics LLC
- Zydus Healthcare Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 765.63 Million |
| Forecasted Market Value ( USD | $ 996.8 Million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | North America |
